Literature DB >> 11727171

Noncontraceptive benefits and therapeutic uses of the oral contraceptive pill.

M Dayal1, K T Barnhart.   

Abstract

The oral contraceptive pill is one of the most extensively studied medications ever prescribed. The health benefits are numerous and outweigh the risks of their use. Definitive evidence exists for protection against ovarian and endometrial cancers, benign breast disease, pelvic inflammatory disease requiring hospitalization, ectopic pregnancy, and iron-deficiency anemia. It has also been suggested that oral contraceptives may provide a benefit on bone mineral density, uterine fibroids, toxic shock syndrome, and colorectal cancer. Minimal supportive evidence exists for oral contraceptives protecting against the development of functional ovarian cysts and rheumatoid arthritis. Treatment of medical disorders with oral contraceptives is an "off-label" practice. Dysmenorrhea, irregular or excessive bleeding, acne, hirsutism, and endometriosis-associated pain are common targets for oral contraceptive therapy. Most patients are unaware of these health benefits and therapeutic uses of oral contraceptives, and they tend to overestimate their risk. Counseling and education are necessary to help women make well-informed health-care decisions and improve compliance.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11727171     DOI: 10.1055/s-2001-18637

Source DB:  PubMed          Journal:  Semin Reprod Med        ISSN: 1526-4564            Impact factor:   1.303


  8 in total

1.  Oral Contraceptives and Cigarette Smoking: A Review of the Literature and Future Directions.

Authors:  Alicia M Allen; Andrea H Weinberger; Reagan R Wetherill; Carol L Howe; Sherry A McKee
Journal:  Nicotine Tob Res       Date:  2019-04-17       Impact factor: 4.244

2.  Evaluating the Cognitive Impacts of Drospirenone, a Spironolactone-Derived Progestin, Independently and in Combination With Ethinyl Estradiol in Ovariectomized Adult Rats.

Authors:  Stephanie V Koebele; Mallori L Poisson; Justin M Palmer; Claire Berns-Leone; Steven N Northup-Smith; Veronica L Peña; Isabel M Strouse; Haidyn L Bulen; Shruti Patel; Corissa Croft; Heather A Bimonte-Nelson
Journal:  Front Neurosci       Date:  2022-05-25       Impact factor: 5.152

3.  Characteristics of scheduled bleeding manipulation with combined hormonal contraception in university students.

Authors:  Hannah Lakehomer; Paul F Kaplan; David G Wozniak; Christopher T Minson
Journal:  Contraception       Date:  2013-01-08       Impact factor: 3.375

4.  Is This a Drug?" Answers From Medical Students in a Tertiary Care Teaching Hospital in Eastern India.

Authors:  Ananya Mandal; Tania Sur Kundu; Parama Sengupta; Arijit Ghosh; Nina Das
Journal:  J Clin Diagn Res       Date:  2016-08-01

5.  Physiologic and psychologic symptoms associated with use of injectable contraception and 20 microg oral contraceptive pills.

Authors:  Abbey B Berenson; Susan D Odom; Carmen Radecki Breitkopf; Mahbubur Rahman
Journal:  Am J Obstet Gynecol       Date:  2008-07-03       Impact factor: 8.661

6.  Decreasing utilization and increasing prices of brand-name oral contraceptive pills: Implications to societal costs and market competition.

Authors:  James X Zhang
Journal:  PLoS One       Date:  2020-06-11       Impact factor: 3.240

7.  Use of simulated patients to evaluate combined oral contraceptive dispensing practices of community pharmacists.

Authors:  Paulo Roque Obreli-Neto; Leonardo Régis Leira Pereira; Camilo Molino Guidoni; André de Oliveira Baldoni; Srecko Marusic; Divaldo Pereira de Lyra-Júnior; Kelsen Luis de Almeida; Ana Claudia Montolezi Pazete; Janaina Dutra do Nascimento; Mitja Kos; Edmarlon Girotto; Roberto Kenji Nakamura Cuman
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

8.  Adherence to the oral contraceptive pill: the roles of health literacy and knowledge.

Authors:  Caitlin Liddelow; Barbara Mullan; Mark Boyes
Journal:  Health Psychol Behav Med       Date:  2020-12-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.